1. Home
  2. ACU vs GALT Comparison

ACU vs GALT Comparison

Compare ACU & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acme United Corporation.

ACU

Acme United Corporation.

HOLD

Current Price

$44.80

Market Cap

154.0M

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$2.97

Market Cap

176.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACU
GALT
Founded
1867
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.0M
176.7M
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
ACU
GALT
Price
$44.80
$2.97
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.50
AVG Volume (30 Days)
8.2K
229.1K
Earning Date
01-01-0001
02-26-2026
Dividend Yield
1.43%
N/A
EPS Growth
N/A
N/A
EPS
2.03
N/A
Revenue
$194,489,991.00
N/A
Revenue This Year
$2.19
N/A
Revenue Next Year
$4.55
N/A
P/E Ratio
$22.07
N/A
Revenue Growth
1.56
N/A
52 Week Low
$35.31
$1.15
52 Week High
$45.60
$7.13

Technical Indicators

Market Signals
Indicator
ACU
GALT
Relative Strength Index (RSI) 57.06 43.31
Support Level $42.98 $2.69
Resistance Level $45.20 $3.00
Average True Range (ATR) 1.17 0.20
MACD -0.07 0.07
Stochastic Oscillator 58.22 44.93

Price Performance

Historical Comparison
ACU
GALT

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: